Bimatoprost Implant System not checked
FollowEvery change as it happens, and a Monday email
Trials
3 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Bimatoprost Implant System used in combination with the SpyGlass IOL”In the company’s words, NCT07218783 on ClinicalTrials.gov
- Tested for
- Cataract (3 trials), Glaucoma (3 trials), Ocular Hypertension (3 trials)
- Main trialPhase 3
- “This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.”In the company’s words, NCT07218783 on ClinicalTrials.gov
Other drugs for Cataract
- TimoD implantEyeD Pharma · Phase 1/2
- ZOC2017217Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. · Phase 2
- Eye dropsAce Cells Lab Limited · Marketed (Phase 4 trial)
Coming up2
- 31 Mar 2029Phase 3 trial completes · ClinicalTrials.gov
- 31 May 2029Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 Mar 2029 | Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) | |
| Phase 3Recruiting | 31 May 2029 | Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone) | |
| Phase 1/2Active, not recruiting | 31 Jan 2025 | Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026